Literature DB >> 33236089

Conversion from video-assisted thoracic surgery (VATS) to thoracotomy during major lung resection: how does it affect perioperative outcomes?

Joseph Seitlinger1, Anne Olland1, Sophie Guinard1, Gilbert Massard1, Pierre-Emmanuel Falcoz1.   

Abstract

OBJECTIVES: Since video-assisted thoracic surgery (VATS) was first performed in the early 1990s, there have been many developments, and the conversion rate has decreased over the years. This article highlights the specific outcomes of patients undergoing conversion to thoracotomy despite initially scheduled VATS lung resection.
METHODS: We retrospectively reviewed 501 patients who underwent thoracoscopic anatomic lung resection (i.e. lobectomy, segmentectomy or bilobectomy) between 1 January 2012 and 1 August 2017 at our institution. We explored the risk factors for surgical conversion and adverse events occurring in patients who underwent conversion to thoracotomy.
RESULTS: A total of 44/501 patients underwent conversion during the procedure (global rate: 8.8%). The main reasons for conversion were (i) anatomical variation, adhesions or unexpected tumour extension (37%), followed by (ii) vascular causes (30%) and (iii) unexpected lymph node invasion (20%). The least common reason for conversion was technical failure (13%). We could not identify any specific risk factors for conversion. The global complication rate was significantly higher in converted patients (40.9%) than in complete VATS patients (16.8%) (P = 0.001). Postoperative atrial fibrillation was a major complication in converted patients (18.2%) [odds ratio (OR) 5.09, 95% confidence interval (CI) 1.80-13.27; P = 0.001]. Perioperative mortality was higher in the conversion group (6.8%) than in the VATS group (0.2%) (OR 33.3, 95% CI 3.4-328; P = 0.003).
CONCLUSIONS: Through the years, the global conversion rate has dramatically decreased to <10%. Nevertheless, patients who undergo conversion represent a high-risk population in terms of complications (40.9% vs 16.8%) and perioperative mortality (6.8% vs 0.2%).
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Conversion; Lung resection; Perioperative complications; Video-assisted thoracic surgery

Mesh:

Year:  2021        PMID: 33236089      PMCID: PMC8906703          DOI: 10.1093/icvts/ivaa220

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  22 in total

1.  Video-assisted thoracoscopic lobectomy: which is the learning curve of an experienced consultant?

Authors:  Antonio Mazzella; Anne Olland; Pierre Emmanuel Falcoz; Stephane Renaud; Nicola Santelmo; Gilbert Massard
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 2.  Enhanced recovery after surgery and video-assisted thoracic surgery lobectomy: the Italian VATS Group surgical protocol.

Authors:  Alessandro Gonfiotti; Domenico Viggiano; Luca Voltolini; Alessandro Bertani; Luca Bertolaccini; Roberto Crisci; Andrea Droghetti
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 3.  Video-assisted thoracic surgery and open chest surgery in lung cancer treatment: present and future.

Authors:  Frank Detterbeck; Laureano Molins
Journal:  J Vis Surg       Date:  2016-12-06

4.  Thoracoscopy assisted pulmonary lobectomy.

Authors:  W S Walker; F M Carnochan; M Tin
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

5.  A method of assessing reasons for conversion during video-assisted thoracoscopic lobectomy.

Authors:  Sayf Gazala; Ian Hunt; Azim Valji; Kenneth Stewart; Ericl R Bédard
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-03-09

6.  Videoendoscopic pulmonary lobectomy for cancer.

Authors:  G Roviaro; C Rebuffat; F Varoli; C Vergani; C Mariani; M Maciocco
Journal:  Surg Laparosc Endosc       Date:  1992-09

7.  Thoracoscopic Surgery Versus Thoracotomy for Lung Cancer: Short-Term Outcomes of a Randomized Trial.

Authors:  Hao Long; Qunyou Tan; Qingquan Luo; Zheng Wang; Gening Jiang; Dongrong Situ; Yongbin Lin; Xiaodong Su; Qing Liu; Tiehua Rong
Journal:  Ann Thorac Surg       Date:  2017-12-02       Impact factor: 4.330

8.  What is difficult about doing video-assisted thoracic surgery (VATS)? A retrospective study comparing VATS anatomical resection and conversion to thoracotomy for lung cancer in a university-based hospital.

Authors:  Si-Wook Kim; Jong-Myeon Hong; Dohun Kim
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

Review 9.  Thoracotomy is better than thoracoscopic lobectomy in the lymph node dissection of lung cancer: a systematic review and meta-analysis.

Authors:  Wenxiong Zhang; Yiping Wei; Han Jiang; Jianjun Xu; Dongliang Yu
Journal:  World J Surg Oncol       Date:  2016-11-17       Impact factor: 2.754

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  3 in total

1.  Clinical Efficacy of Thoracoscopic Surgery with the da Vinci Surgical System versus Video-Assisted Thoracoscopic Surgery for Lung Cancer.

Authors:  Jin-Cai Zhou; Wu-Ping Wang; Shu-Qiang Wu; Jia-Lin Wang; Wen-Hai Li
Journal:  J Oncol       Date:  2022-06-08       Impact factor: 4.501

2.  Is faster better? Impact of operative time on postoperative outcomes after VATS anatomical pulmonary resection.

Authors:  Céline Forster; Arpad Hasenauer; Jean Yannis Perentes; Etienne Abdelnour-Berchtold; Matthieu Zellweger; Thorsten Krueger; Michel Gonzalez
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

3.  [Reasons for Conversion to Thoracotomy in 83 Cases during Video-assisted Thoracic Surgery Lobectomy: A Summary of 1,350 Consecutive Operations by A Single Surgical Team].

Authors:  Peng Su; Shiwang Wen; Mingbo Wang; Yanzhao Xu; Huilai Lv; Zhenhua Li; Ziqiang Tian
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-06-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.